Effect of the PIPAC on the Survival Rate of Patients With Peritoneal Carcinomatosis of Gastric Origin

Carcinomatosis, Peritoneal Clinical Trial

Official title:
Effect of Pressurised Intraperitoneal Aerosol Chemotherapy on the Survival Rate of Patients With Peritoneal Carcinomatosis of Gastric Origin

Status Completed

Clinical Trial Summary

Pressurised intraperitoneal aerosol chemotherapy is a new surgical technique, developed for the treatment of initially unresectable peritoneal carcinomatosis. The objective of this study was to compare the results of PIPAC associated with systemic chemotherapy with those of systemic chemotherapy alone in patients with gastric peritoneal carcinomatosis without metastasis other than peritoneal, and WHO performance status <3.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT04879953
Study type	Observational
Source	Association Francaise de Chirurgie
Contact
Status	Completed
Phase
Start date	February 1, 2020
Completion date	December 31, 2020

View Details

See also
	Status	Clinical Trial	Phase
	Recruiting	`NCT04512209` - Characterization of Biophysical Stromal Properties in Human Cancer: Towards Personalized Computational Oncology	N/A
	Completed	`NCT06237582` - Inferior Epigastric Lymp Node (IELN) Basin as a Possible Systemic Metastatic Pathway of Ovarian Peritoneal Metastases	N/A